Virtual Library

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    Bristol-Myers Squibb - Industry Satellite Symposium

    • Type: Industry Satellite symposium
    • Presentations: 6
    • Coordinates: 4/10/2019, 18:15 - 19:15, Room A
  • +

    Immunotherapy in stage IV

    • Type: Educational session
    • Presentations: 6
    • Coordinates: 4/11/2019, 09:00 - 10:30, Room B
  • +

    Lunch & Poster Display session

    • Type: Poster Display session
    • Presentations: 170
    • Coordinates: 4/11/2019, 12:30 - 13:00, Hall 1
    • +

      66P - Treatment (tx) characteristics and clinical outcomes in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) treated with carboplatin (carbo) or cisplatin (cis) in combination with etoposide (etop) in US clinical practice

      12:30 - 12:30  |  Presenter: Martin Sebastian

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      82TiP - IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy

      12:30 - 12:30  |  Presenter: Solange Peters

      • Abstract

      Loading...

    • +

      125P - Elderly patients treated with afatinib in clinical practice: Results from the prospective non-interventional study GIDEON

      12:30 - 12:30  |  Presenter: Wolfgang Brückl

      • Abstract

      Loading...

  • +

    ESMO-IASLC Best Abstracts

    • Type: Proffered Paper session
    • Presentations: 7
    • Coordinates: 4/11/2019, 14:45 - 16:15, Room B
    • +

      LBA1_PR - Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study

      14:45 - 15:00  |  Presenter: Taofeek K Owonikoko

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      103O_PR - Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1–positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042

      15:45 - 16:00  |  Presenter: Kaname Nosaki

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Boehringer Ingelheim - Industry Satellite Symposium

    • Type: Industry Satellite symposium
    • Presentations: 6
    • Coordinates: 4/11/2019, 18:00 - 19:00, Room A
    • +

      Recent changes and sequencing strategies in non-mutated, non-squamous advanced NSCLC

      18:30 - 18:45  |  Presenter: Martin Reck

      • Abstract

      No abstract available for this presentation

  • +

    Proffered Paper session III

    • Type: Proffered Paper session
    • Presentations: 8
    • Coordinates: 4/12/2019, 08:30 - 10:00, Room A